Nairo Quintana’s Tour de France tramadol disqualification upheld

CAS uphold the UCI decision to disqualify the Colombian after painkiller detected in blood tests

Nairo Quintana
(Image credit: Getty)

The decision to disqualify Nairo Quintana from the 2022 Tour de France by the UCI has been upheld by the Court of Arbitration for Sport [CAS]. 

Quintana returned a positive test during the race for tramadol on two separate occasions.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Tom Thewlis
News and Features Writer

Tom has been writing for Cycling Weekly since 2022 and his news stories, rider interviews and features appear both online and in the magazine. 

Since joining the team, he has reported from some of professional cycling's biggest races and events including the Tour de France and the World Championships in Glasgow. He has also covered major races elsewhere across the world. As well as on the ground reporting, Tom writes race reports from the men's and women's WorldTour and focuses on coverage of UK domestic cycling.